LPP rs9865818: Genetics of Allergic Rhinitis and Sensitization
The rs9865818 polymorphism is an intronic single nucleotide variant located in the LPP gene on chromosome 3. Large-scale genome-wide association studies have identified it as a susceptibility marker associated with allergic sensitization, elevated serum allergen-specific IgE positivity, and allergic rhinitis. Possessing the risk-associated allele confers a modest statistical increment in susceptibility rather than causing allergies directly.
What each genotype means
Typical allergy risk
You carry two copies of the common G allele at this regulatory position in the LPP gene. Large-scale genome-wide association studies show that this genotype is associated with baseline population odds for allergen-specific IgE sensitization and allergic rhinitis. Carrying this baseline profile does not prevent environmental allergies, which are shaped by many lifestyle and genetic factors.
Found in approximately 55% to 60% of individuals of European descent and around 75% to 80% of individuals of East Asian ancestry.
Moderately increased allergic rhinitis risk
You carry one copy of the A risk allele associated with altered immune regulation near the LPP gene. Published genetic association studies indicate this genotype is linked to modestly higher odds of producing allergen-specific IgE antibodies and developing allergic rhinitis compared to the baseline genotype. Because this variant represents a single contribution among many genetic and environmental triggers, carrying it does not mean an allergy diagnosis is inevitable.
Carried by roughly 35% of individuals of European ancestry and approximately 20% to 22% of individuals in East Asian populations.
Elevated allergic rhinitis risk
You carry two copies of the A risk allele in the LPP locus. Studies show that having two risk alleles confers a stronger statistical association with serum allergen-specific IgE positivity and clinical allergic rhinitis compared to non-carriers. This finding describes statistical risk in populations rather than a clinical diagnosis, as non-genetic triggers and overall immune health strongly influence actual symptoms.
Observed in roughly 5% of European populations and only about 1% to 2% of East Asian populations.
Genomic Location and Variant Classification
The single nucleotide polymorphism rs9865818 is mapped to chromosome 3q27.3-q28 within an intronic region of the LPP (LIM Domain Containing Preferred Translocation Partner In Lipoma) gene. This variant represents an A-to-G transition. Because it resides in an non-coding intronic region rather than within an exon, it does not alter the primary amino acid sequence of the encoded protein. Instead, bioinformatic and functional genetics frameworks categorize it as a putative cis-regulatory variant. It is hypothesized to influence transcriptional efficiency, alternative splicing, or chromatin accessibility at the LPP locus. Genome-wide association data indexed in the GWAS Catalog highlight rs9865818 as a sentinel marker in high linkage disequilibrium with regulatory regions controlling immune-related gene expression in human mucosal and lymphoid tissues.
Biological Role of the LPP Gene
The LPP gene encodes a member of the zyxin family of LIM domain-containing proteins. Structurally, LPP features an N-terminal proline-rich region that binds to actin-associated cytoskeletal proteins and three tandem C-terminal LIM domains that facilitate specific protein-protein interactions. LPP primarily shuttles between focal adhesions at the cell membrane and the cell nucleus, where it can function as a transcriptional co-activator responding to mechanical and inflammatory stimuli. Beyond its mechanical role in cell motility and barrier maintenance, LPP has been widely implicated in inflammatory and immune signaling. Disruption in mucosal adhesion, epithelial barrier integrity, or related transcriptional cascades can facilitate heightened allergen entry and inappropriate mucosal immune priming, forming a plausible mechanistic link between LPP variation and hyper-reactive immune phenotypes.
Evidence for Allergic Sensitization and Rhinitis
Extensive genetic research links rs9865818 to allergic traits across diverse populations. Landmark meta-analyses of genome-wide association studies, such as research published in Nature Genetics (PMID 23817571), identified rs9865818 as a genome-wide significant susceptibility locus for allergic sensitization, defined by serum allergen-specific IgE positivity. In these discovery cohorts, the minor G allele conferred an odds ratio of approximately 1.12 per copy. Subsequent targeted association analyses and replications, including studies evaluated across European cohorts and Chinese Han populations, have expanded these findings to clinical diagnoses of allergic rhinitis (hay fever). Although the statistical evidence is strong and replicated across multiple cohorts, the absolute effect size is modest, demonstrating that rs9865818 acts as one of hundreds of small-effect polygenic contributors to mucosal allergic conditions.
Population Genetics and Ancestry Patterns
The frequency of rs9865818 alleles varies markedly depending on geographic and genetic ancestry. In populations of European descent, the minor G allele has an approximate frequency of 0.23, meaning nearly 40% of European individuals carry at least one copy of the variant allele. In East Asian populations, including Han Chinese cohorts, the G allele occurs at an estimated frequency of 0.12. Across global population datasets like 1000 Genomes and gnomAD, the non-risk A allele remains the predominant ancestral allele. These frequency differences mean that while the biological effect of the allele is consistent across ancestries, its overall contribution to population-attributable allergic risk varies globally.
Practical Implications and Clinical Interpretation
Knowledge of an individual's rs9865818 genotype does not provide a medical diagnosis of allergic disease, nor does it predict definitive clinical outcomes. Allergic rhinitis and atopic sensitization are complex, multifactorial traits governed by hundreds of common genetic variants interacting with diverse environmental exposures, such as pollen counts, dust mite contact, pet dander, childhood viral infections, and air quality. A person carrying two copies of the G allele may never manifest symptoms, whereas an individual with the AA genotype may experience severe seasonal allergies. Direct-to-consumer genetic testing results should be viewed strictly through an educational lens. Any decisions regarding allergy testing, immunotherapy, or symptom management should be made in consultation with a qualified allergist or medical provider.
How common is this variant?
The minor G allele has a frequency of approximately 0.23 in European ancestries and about 0.12 in East Asian populations, with the non-risk A allele being the predominant variant worldwide.
Frequently asked questions
Does having the rs9865818 G allele mean I will definitely develop allergies?
No. The rs9865818 G allele is merely an associated statistical risk factor with an odds ratio of approximately 1.12 per copy. Allergic diseases are polygenic and heavily reliant on environmental factors such as allergen exposure, climate, and microbiome diversity.
Can this genetic variant help determine which specific allergens affect me?
No. Research links rs9865818 broadly to allergic sensitization, which reflects general allergen-specific IgE positivity, but the variant does not specify individual triggers such as ragweed, birch, cats, or dust mites. Specific sensitivities are diagnosed using clinical skin-prick testing or allergen-specific serum blood panels.
Is the LPP gene involved in other immune conditions?
Yes. Polymorphisms within and surrounding the LPP locus have been investigated in genome-wide association studies for other immune-mediated and inflammatory traits, including celiac disease and vitiligo, due to the gene's role in epithelial cell adhesion and cell signaling.
Should I alter my allergy medications based on my rs9865818 genotype?
No. Variant rs9865818 is an association marker for disease susceptibility, not a pharmacogenomic marker that dictates medication response or dosing. You should never alter antihistamines, nasal corticosteroids, or immunotherapy protocols without speaking to your doctor or pharmacist.
Sources & further reading
Educational information only, last refreshed 9/11/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs9865818?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29